Intra-Cellular Therapies, Inc.
Hedge Funds Holdings
Last updated:
Intra-Cellular Therapies, Inc.‘s stocks are currently a part of 230 hedge funds’ portfolios, which represents 98.28% of the total amount of its stocks outstanding. This makes up a total of 79.85M shares of Intra-Cellular Therapies, Inc.. Compared to the previous quarter, the number grew by 16.24% or 11.15M shares more. As for the holding position changes, 36.96% (85) of current hedge fund investors increased the number of shares held, 27.39% (63) of current holders sold a part of the shares held, and 13.91% (32) closed the holdings completely. 66 hedge funds are new holders of Intra-Cellular Therapies, Inc. stock in Q1 2022, it is 28.7% of total holders.
Hedge funds holding Intra-Cellular Therapies (Q2 2017 – Q1 2022)
| Q2 2017 | 101 |
|---|---|
| Q3 2017 | 139 |
| Q4 2017 | 131 |
| Q1 2018 | 132 |
| Q2 2018 | 132 |
| Q3 2018 | 132 |
| Q4 2018 | 126 |
| Q1 2019 | 125 |
| Q2 2019 | 125 |
| Q3 2019 | 126 |
| Q4 2019 | 132 |
| Q1 2020 | 136 |
| Q2 2020 | 147 |
| Q3 2020 | 172 |
| Q4 2020 | 174 |
| Q1 2021 | 163 |
| Q2 2021 | 178 |
| Q3 2021 | 172 |
| Q4 2021 | 200 |
| Q1 2022 | 230 |
Hedge funds changes in Intra-Cellular Therapies positions (Q2 2017 – Q1 2022)
| Q2 2017 | 12 | 35 | 29 | 26 | -1 |
|---|---|---|---|---|---|
| Q3 2017 | 48 | 43 | 23 | 10 | 15 |
| Q4 2017 | 19 | 54 | 33 | 27 | -2 |
| Q1 2018 | 21 | 42 | 47 | 18 | 4 |
| Q2 2018 | 14 | 51 | 44 | 13 | 10 |
| Q3 2018 | 11 | 41 | 48 | 11 | 21 |
| Q4 2018 | 14 | 43 | 48 | 19 | 2 |
| Q1 2019 | 10 | 53 | 28 | 12 | 22 |
| Q2 2019 | 18 | 46 | 31 | 13 | 17 |
| Q3 2019 | 26 | 42 | 35 | 24 | -1 |
| Q4 2019 | 30 | 36 | 47 | 24 | -5 |
| Q1 2020 | 31 | 64 | 26 | 25 | -10 |
| Q2 2020 | 33 | 60 | 32 | 21 | 1 |
| Q3 2020 | 46 | 71 | 38 | 20 | -3 |
| Q4 2020 | 40 | 60 | 51 | 38 | -15 |
| Q1 2021 | 21 | 50 | 66 | 29 | -3 |
| Q2 2021 | 31 | 56 | 67 | 15 | 9 |
| Q3 2021 | 22 | 74 | 48 | 27 | 1 |
| Q4 2021 | 49 | 56 | 66 | 20 | 9 |
| Q1 2022 | 66 | 85 | 63 | 32 | -16 |
Hedge funds changes in Intra-Cellular Therapies stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 6,760,000 | 1,502,000 |
|---|---|---|
| Q3 2017 | 6,907,000 | 14,238,000 |
| Q4 2017 | 10,683,200 | 6,702,000 |
| Q1 2018 | 30,801,000 | 20,986,000 |
| Q2 2018 | 35,355,000 | 20,539,000 |
| Q3 2018 | 49,942,000 | 26,261,000 |
| Q4 2018 | 49,346,000 | 11,765,000 |
| Q1 2019 | 42,628,000 | 4,381,000 |
| Q2 2019 | 51,744,000 | 21,921,000 |
| Q3 2019 | 15,399,000 | 26,187,000 |
| Q4 2019 | 259,994,000 | 548,551,000 |
| Q1 2020 | 10,878,000 | 7,692,000 |
| Q2 2020 | 91,404,000 | 41,259,000 |
| Q3 2020 | 38,171,000 | 30,989,000 |
| Q4 2020 | 30,058,000 | 21,280,000 |
| Q1 2021 | 22,694,000 | 18,302,000 |
| Q2 2021 | 38,983,000 | 11,362,000 |
| Q3 2021 | 30,963,000 | 7,670,000 |
| Q4 2021 | 68,152,000 | 31,436,000 |
| Q1 2022 | 33,670,000 | 16,351,000 |